Source Data presented at PCR London Valves 2024 showed that caval valve implantation (CAVI) with the TricValve® system demonstrates an acceptable safety profile and significant clinical benefits in highly comorbid patients with severe tricuspid regurgitation (TR), according to the TricBicaval registry’s one-year findings.  Severe TR poses

Performed in Spain at the University Hospital of Salamanca Dr. Javier Martín Moreiras MD, PhD Interventional Cardiologist and Associated Professor of Cardiology. University Hospital of Salamanca, Spain An 83-year-old woman with a long history of rheumatic valvular heart disease underwent a percutaneous mitral valvuloplasty performed

Performed in Spain at Ramón y Cajal University Hospital Dr. Ángel Sánchez Recalde Head of Interventional Cardiology at Ramón y Cajal University Hospital in Madrid, Spain A 69-year-old male patient with symptoms of heart failure who developed tricuspid regurgitation was admitted after several episodes of